Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2014-03-18EMA Lapsed: Leflunomide Teva (leflunomide) — Teva Pharma B.V.
EMA status shows Leflunomide Teva (leflunomide) has lapsed its authorization in the European market.
-
CLINICAL_TRIALS withdrawal · 2013-09-16Clinical Trial Update: BIIB057 in Subjects With Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs [Phase 2]
A Phase 2 study of BIIB057 in rheumatoid arthritis patients with inadequate response to disease-modifying antirheumatic drugs has been withd…
-
CLINICAL_TRIALS withdrawal · 2013-07-02Clinical Trial Update: Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants [Phase 4]
This is a Phase 4 clinical trial in rheumatoid arthritis investigating TNF-alpha–induced pre-B cell bone marrow emigrants, which has been wi…
-
CLINICAL_TRIALS withdrawal · 2012-10-31Clinical Trial Update: Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99
Expanded Access Trial of belimumab for rheumatoid arthritis is no longer available.
-
CLINICAL_TRIALS withdrawal · 2012-05-21Clinical Trial Update: Role of Chemokines and Proinflammatory Cytokines in Rheumatoid Synovial Pathological Changes
The clinical trial examining chemokines and proinflammatory cytokines in rheumatoid synovial pathology has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2010-12-03Clinical Trial Update: A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients [Phase 1]
A Phase 1 pharmacokinetic study of methotrexate with and without AZD9056 in rheumatoid arthritis has been withdrawn.
-
EMA withdrawal · 2010-02-03EMA Withdrawn: Bextra (valdecoxib) — Pharmacia - Pfizer EEIG
The EMA indicates Bextra (valdecoxib) has been withdrawn from the market by Pharmacia - Pfizer EEIG.
-
EMA withdrawal · 2008-02-14EMA Withdrawn: Trudexa (adalimumab) — Abbott Laboratories Ltd.
EMA has withdrawn Trudexa (adalimumab) from the market.